Efficacy and safety of glucagon-like peptide-1 (GLP-1) agonists in pediatric obesity: A systematic review and meta-analysis
{{output}}
Background: Childhood obesity is a growing public health concern associated with long-term metabolic and cardiovascular complications. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have shown efficacy in reducing weight, ... ...
